The Centers for Medicare and Medicaid Services’ final Inpatient Prospective Payment System (IPPS) rule has drawn both criticism and praise, according to a Fierce Healthcare report.
Leapfrog Group President Leah Binder said the organization is opposed to the agency cutting “critical patient safety and infection measures” from the Inpatient Quality Reporting Program.
“There should be no compromise in public access to critical, life-and-death information about hospitals,” she told Fierce Healthcare.
According to the report, some other measures to be cut include:
- Catheter-associated urinary tract infection rates;
- Clostridium difficile infection rates;
- Surgical site infections related to hysterectomy or colon procedures; and
- Methicillin-resistant Staphylococcus aureus infection rates.
Leapfrog did, however, back CMS’ decision to roll back adjustments to the Value-Based Purchasing Program.
Click here to read the full report on Fierce Healthcare.
